Literature DB >> 20146024

Inhibitory effect of galanin on adrenaline- and noradrenaline-induced increased oxytocin secretion in rat neurohypophyseal cell cultures.

Marianna Radács1, Andor H Molnár, Ferenc A László, Csaba Varga, Ferenc László, Márta Gálfi.   

Abstract

The effects of the interactions between the 29 amino acid-containing peptide galanin and adrenaline or noradrenaline on the secretion of oxytocin were studied in 13- to 14-day cultures of isolated rat neurohypophyseal tissue. The alpha-receptor antagonist corynanthine blocked the adrenaline-induced increase of oxytocin secretion. When the beta-receptor antagonist propranolol was added before the noradrenaline treatment, the antagonist prevented the noradrenaline-induced enhancement of oxytocin release. Following the addition of galanin, the extent of oxytocin secretion into the supernatant medium decreased. Adrenaline and noradrenaline treatments increased the oxytocin level. Preincubation with galanin reduced the adrenaline- and noradrenaline-induced oxytocin level elevations. The blocking effect of galanin was prevented by previous treatment with the galanin receptor antagonist galantid (M15). When adrenaline or noradrenaline treatment was applied before galanin addition, the oxytocin secretion remained enhanced. The present results indicate that the changes in oxytocin secretion induced by the adrenergic system can be directly influenced by the galaninergic system. The interactions between the adrenergic and galaninergic systems from the aspect of oxytocin secretion can occur at the level of the posterior pituitary, independently of the hypothalamus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20146024     DOI: 10.1007/s12031-010-9331-3

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  53 in total

1.  Galanin immunoreactive neurons in the medulla oblongata of rats.

Authors:  M Palkovits; S Horváth
Journal:  Acta Biol Hung       Date:  1994

2.  Isolation and primary structure of pituitary human galanin, a 30-residue nonamidated neuropeptide.

Authors:  W E Schmidt; H Kratzin; K Eckart; D Drevs; G Mundkowski; A Clemens; S Katsoulis; H Schäfer; B Gallwitz; W Creutzfeldt
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

Review 3.  Neurotransmitter/neuropeptide interactions in the regulation of neurohypophyseal hormone release.

Authors:  C D Sladek; J R Kapoor
Journal:  Exp Neurol       Date:  2001-10       Impact factor: 5.330

4.  Galanin lacks binding sites in the porcine pituitary and has no detectable effect on oxytocin and vasopressin release from rat neurosecretory endings.

Authors:  W Gaymann; N Falke
Journal:  Neurosci Lett       Date:  1990-04-20       Impact factor: 3.046

5.  Isolation and cDNA cloning of a novel galanin-like peptide (GALP) from porcine hypothalamus.

Authors:  T Ohtaki; S Kumano; Y Ishibashi; K Ogi; H Matsui; M Harada; C Kitada; T Kurokawa; H Onda; M Fujino
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

6.  Effects of dopamine and dopamine-active compounds on oxytocin and vasopressin production in rat neurohypophyseal tissue cultures.

Authors:  M Gálfi; T Janáky; R Tóth; G Prohászka; A Juhász; C Varga; F A László
Journal:  Regul Pept       Date:  2001-04-02

7.  Galanin stimulates the release of cholecystokinin from nerve fibres in the pituitary neurointermediate lobe.

Authors:  B Meister; A L Hulting; K Uvnäs-Moberg; T Hökfelt
Journal:  Neuroreport       Date:  1993-06       Impact factor: 1.837

Review 8.  Galanin--10 years with a neuroendocrine peptide.

Authors:  K Bedecs; M Berthold; T Bartfai
Journal:  Int J Biochem Cell Biol       Date:  1995-04       Impact factor: 5.085

9.  Histamine-induced enhancement of vasopressin and oxytocin secretion in rat neurohypophyseal tissue cultures.

Authors:  M Radács; M Gálfi; A Juhász; Cs Varga; A Molnár; F László; F A László
Journal:  Regul Pept       Date:  2006-03-10

Review 10.  Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain.

Authors:  John D Fernstrom; Madelyn H Fernstrom
Journal:  J Nutr       Date:  2007-06       Impact factor: 4.798

View more
  1 in total

1.  Galanin receptors and ligands.

Authors:  Kristin E B Webling; Johan Runesson; Tamas Bartfai; Ulo Langel
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-07       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.